Data provided by Nasdaq. Minimum 15 minutes delayed.
November 15, 2017
NantHealth Ranked Number 304 Fastest Growing Company in North America on Deloitte’s 2017 Technology Fast 500™
Company attributes 276 percent revenue growth in 2017 to GPS Cancer™ and advanced oncology solutions CULVER CITY, Calif.--(BUSINESS WIRE)--Nov. 15, 2017-- NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, announced today a ranking of 304 on Deloitte’s Technology Fast 500™, a ranking of the 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies in ...
November 09, 2017
NantHealth Reports 2017 Third Quarter Financial Results; GPS Revenue Doubles from Preceding Quarter
GPS Revenue Exceeds $1.0 Million in Q3, Up 128% from Q2 547 GPS Commercial Tests Ordered in Q3, Up 44% from Q2 204 GPS Tests Ordered in October, Largest Month of Orders to Date Signed New International Reseller, Expanding Global Coverage to Select Southeast Asia Markets Executed on Sale of Provider/Patient Engageme...
November 03, 2017
NantHealth to Report 2017 Third-Quarter Financial Results and Host Conference Call on Thursday, November 9
CULVER CITY, Calif.--(BUSINESS WIRE)--Nov. 3, 2017-- NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that it will report financial results for its 2017 third quarter on Thursday, November 9, 2017, after market close. NantHealth management will host a conference call that same day at 1:30 p.m. PT (4:30 p.m. ET) to review the company’s performance. The conference call will...
|There are currently no events scheduled.|